KRRO.NASDAQKorro Bio, INC

Form 4: Korro Bio Director Rick Yang Acquires Shares Via Subscription Agreement

Sentiment:

SEC Form 4 Filing


Rick Yang, a director at Korro Bio, acquired 17,857 shares of common stock at $56 per share on April 22, 2024, through a subscription agreement.

Summary

  • On April 22, 2024, Rick Yang, a director of Korro Bio, acquired 17,857 shares of common stock.
  • The shares were purchased at a price of $56 per share.
  • The acquisition was made pursuant to a Subscription Agreement dated April 17, 2024.
  • Following the transaction, Yang indirectly owns 1,090,793 shares through NEA 17 GP, LLC, the sole general partner of NEA Partners 17, L.P., which is the sole general partner of New Enterprise Associates 17, L.P. ('NEA 17').
  • Yang disclaims beneficial ownership of the securities held by NEA 17 in which he has no direct pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares at $56 can be seen as a positive signal, but it's a routine transaction.

Positives

  • A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.

Key Dates

DateDescription
2024-02-29Date of Power of Attorney document.
2024-04-17Date of the Subscription Agreement.
2024-04-22Date of the transaction (share acquisition).
2024-04-24Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.